Quick Search

 

 


 

 

Result Summary for 208141/023

Result Summary
Protocol ID: 208141/023
Clinical Study ID: 208141/023
Official Title: A double-blind study to compare between groups, in healthy HSV-seronegative adolescent subjects, the humoral and cellular immune response and the reactogenicity of herpes simplex candidate vaccines containing gD (10µg or 20µg) and 2 doses of Al-MPL.
Phase: phase 2
Study Indications or Diseases:
  • Herpes Simplex Virus
Generic Name: Herpes Simplex Vaccine
Trade/Product Name: Herpes Simplex Vaccine
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.